文献速递流行病学与生物统计医学教育与科研方法

病原体基因型或基因群系统综述中常不恰当地使用未加权汇总统计量

Frequent inappropriate use of unweighted summary statistics in systematic reviews of pathogen genotypes or genogroups.
PubMed 文献 · J Clin Epidemiol · 2019-11-15

该研究系统评估病原体基因型/基因群流行病学系统综述的方法学质量,共纳入36篇文章,其中5篇(14%)仅做系统综述、16篇(44%)进行Meta分析、15篇(42%)使用汇总统计量。多变量线性回归显示Meta分析在AMSTAR和PRISMA评分上质量高于使用汇总统计量的研究,仅系统综述组与汇总统计量组在AMSTAR、PRISMA和ROBIS三个量表上得分大致相等,方法学质量从1999年至2017年有所改善。

要点

  • 36篇纳入文献中15篇(42%)使用未加权汇总统计量,16篇(44%)行Meta分析。
  • Meta分析在AMSTAR和PRISMA评分上高于使用汇总统计量的研究。
  • 仅系统综述组与汇总统计量组在AMSTAR、PRISMA、ROBIS得分上大致相等。

核心结论

  • 尽管未加权汇总统计量被频繁使用,Meta分析仍是病原体基因型/基因群流行病学研究得出合理结论的最适宜方法。

研究设计与样本

  • 系统评估病原体基因型/基因群流行病学系统综述和Meta分析方法学质量的研究,检索九个电子数据库并手工检索参考文献列表。
  • 将方法类型分为三组:加权合并分析(称为Meta分析)、研究水平测量的未加权分析(称为汇总统计量)、不做任何数据合并(称为仅系统综述)。
  • 使用AMSTAR、PRISMA和ROBIS工具评估特征,方案在PROSPERO注册(CRD42017078146)。
  • 共纳入36篇文章:5篇(14%)仅系统综述、16篇(44%)行Meta分析、15篇(42%)使用汇总统计量。

主要发现

  • AMSTAR和PRISMA评分的单变量和多变量线性回归显示,Meta分析组质量高于使用汇总统计量的研究。
  • 仅系统综述组与汇总统计量组在AMSTAR、PRISMA和ROBIS三个量表上得分大致相等。
  • 流行病学研究的方法学质量从1999年至2017年有所改善。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our study aimed to systematically assess and report the methodological quality used in epidemiological systematic reviews (SRs) and meta-analysis (MA) of pathogen genotypes/genogroups. STUDY DESIGN AND SETTING: Nine electronic databases and manual search of reference lists were used to identify relevant studies. The method types were divided into three groups: 1) with weighted pooling analysis (which we call MA), (2) unweighted analysis of the study-level measures (which we call summary statistics), and (3) without any data pooling (which we call SR only). Characteristics were evaluated using Assessment of Multiple Systematic Reviews (AMSTAR), Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), and Risk Of Bias In Systematic reviews (ROBIS) tools. The protocol was registered in PROSPERO with CRD42017078146. RESULTS: Among 36 included articles, 5 (14%) studies conducted SR only, 16 (44%) performed MA, and 15 (42%) used summary statistics. The univariable and multivariable linear regression of AMSTAR and PRISMA scores showed that MA had higher quality compared with those with summary statistics. The SR only and summary statistics groups had approximately equal scores among three scales of AMSTAR, PRISMA, and ROBIS. The methodological quality of epidemiological studies has improved from 1999 to 2017. CONCLUSION: Despite the frequent use of unweighted summary statistics, MA remains the most suitable method for reaching rational conclusions in epidemiological studies of pathogen genotypes/genogroups.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Tran L, Nhu Y M, Le Ba Nghia T, et al. Frequent inappropriate use of unweighted summary statistics in systematic reviews of pathogen genotypes or genogroups. J Clin Epidemiol. 2019. PMID: 31740320. doi:10.1016/j.jclinepi.2019.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。